Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OLMA

Olema Pharmaceuticals (OLMA)

Olema Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OLMA
DateTimeSourceHeadlineSymbolCompany
06/09/20235:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/08/20235:06PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/05/20236:23PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/05/20235:32PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/02/20234:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/30/20234:30PMGlobeNewswire Inc.Olema Oncology to Present at the 2023 Jefferies Healthcare ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
05/19/20231:09PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/11/20239:25AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/11/20238:43AMGlobeNewswire Inc.Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 StudyNASDAQ:OLMAOlema Pharmaceuticals Inc
05/09/20234:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/09/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/09/20234:01PMGlobeNewswire Inc.Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
05/08/20237:06AMGlobeNewswire Inc.Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual CongressNASDAQ:OLMAOlema Pharmaceuticals Inc
05/02/20234:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
04/28/20234:06PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OLMAOlema Pharmaceuticals Inc
04/13/20234:30PMGlobeNewswire Inc.Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
04/04/20234:30PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/29/202312:37PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/22/20236:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/10/20234:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/09/20234:34PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/09/20234:16PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/09/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/09/20234:00PMGlobeNewswire Inc.Olema Oncology Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Strategic UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
03/02/20235:00PMGlobeNewswire Inc.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OLMAOlema Pharmaceuticals Inc
03/02/20234:05PMGlobeNewswire Inc.Olema Oncology to Present at Oppenheimer 33rd Annual Healthcare ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
02/21/20234:30PMGlobeNewswire Inc.Olema Oncology to Participate at Upcoming Investor ConferencesNASDAQ:OLMAOlema Pharmaceuticals Inc
02/14/20233:46PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/14/20233:09PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
02/10/202311:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OLMAOlema Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OLMA